Drug Trial Radar · NCT02160041
BGJ398 for Patients With Tumors With FGFR Genetic Alterations
Last checked: Nov 20, 2026Latest source record: Jun 18, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
84
Actual
Start
Jul 24, 2014
Primary completion
Apr 30, 2018
Study completion Apr 30, 2018
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Jun 10, 2014
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this signal seeking study was to determine whether treatment with BGJ398 demonstrates sufficient efficacy in select FGFR pathway-regulated solid tumors and/or hematologic malignancies to warrant further study.
Conditions
- Solid Tumor
- Hematologic Malignancies
Interventions
BGJ398Drug
BGJ398 was dosed on a flat scale of 125 mg (e.g., 1 x 100 mg and 1 x 25 mg capsules) once daily for the first 21 days of the 28-day cycle (3 weeks on, 1 week off in a cycle). A complete treatment cycle is defined as 28 days.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical Benefit Rate (CBR) Associated With BGJ398 TreatmentTime frame: 16 weeks
Locations
56 sites in 1 country. Site status is shown where the registry gives one.
Alabama Oncology St. Vincent's Birmingham
Birmingham, Alabama
North County Oncology Medical Clinic Inc
Oceanside, California
San Francisco General Hospital San Francisco Gen Hosp (7)
San Francisco, California
Rocky Mountain Cancer Centers Rocky Mountain Cancer Ctr (50)
Greenwood Village, Colorado
Norwalk Hospital
Norwalk, Connecticut
Florida Cancer Specialists Florida Cancer Specialists 36
Fort Myers, Florida
University of Miami Sylvester Comprehensive Cancer
Miami, Florida
NorthWest Georgia Oncology Centers NW Georgia Oncology
Marietta, Georgia
Harbin Clinic Medical Oncology Clin. Res.
Rome, Georgia
Illinois Cancer Specialists
Arlington Heights, Illinois
Lurie Children's Hospital of Chicago Developmental Therapeutics
Chicago, Illinois
Community Clinical Research Center
Anderson, Indiana
Indiana University Indiana Univ. - Purdue Univ.
Indianapolis, Indiana
Northern Indiana Cancer Research Consortium No. Indiana Cancer Res.
South Bend, Indiana
University of Louisville / James Graham Brown Cancer Center SC
Louisville, Kentucky
St. Agnes Hospital St. Agnes Hospital (2)
Baltimore, Maryland
Southcoast Centers for Cancer Care
Fairhaven, Massachusetts
Cancer and Hematology Centers of West Michigan Dept. of Oncology
Grand Rapids, Michigan
Minnesota Oncology Hematology, P.A. Minnesota Oncology Hem (27)
Minneapolis, Minnesota
Research Medical Center Research Med Center (2)
Kansas City, Missouri
Billings Clinic Billings Clinic (8)
Billings, Montana
Dartmouth Hitchcock Medical Center Dartmouth Hitchcock - Lebanon
Bedford, New Hampshire
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey
New Mexico Cancer Center
Albuquerque, New Mexico
Waverly Hematology Oncology
Cary, North Carolina
University of N C at Chapel Hill Physician Office Building
Chapel Hill, North Carolina
Duke University Medical Center Seeley G. Mudd Bldg.
Durham, North Carolina
Wake Forest Baptist Health Hem & Onc Medical Center
Winston-Salem, North Carolina
Sanford Hematology Oncology
Fargo, North Dakota
Oncology Hematology Care Inc Oncology Hematology Care 2
Cincinnati, Ohio
University Hospitals of Cleveland Seidman Cancer Center University Hospitals
Cleveland, Ohio
Cleveland Clinic Foundation Taussig Cancer Institute
Cleveland, Ohio
Bend Memorial Clinic Bend Mem. Clinic
Bend, Oregon
Northwest Cancer Specialists Northwest Cancer
Portland, Oregon
Lehigh Valley Health Network
Allentown, Pennsylvania
Cancer Treatment Centers of America Eastern Regional Medical Center
Philadelphia, Pennsylvania
University of Pittsburgh Cancer Institute Hillman Cancer Center (2)
Pittsburgh, Pennsylvania
Rhode Island Hospital Rhode Island Hosp. (2)
Providence, Rhode Island
Sanford University of South Dakota Medical Center Sanford Health
Sioux Falls, South Dakota
Chattanooga Oncology and Hematology Assoicates, PC Chattanooga Oncology
Chattanooga, Tennessee
Showing 40 of 56 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.